CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts-Reference-Cited by-同舟云学术

CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

Published:2018-02-27 Issue:11 Volume:14 Page:1470-1481
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Hansson Oskar¹²,Seibyl John³,Stomrud Erik¹²,Zetterberg Henrik⁴⁵⁶⁷,Trojanowski John Q.⁸,Bittner Tobias⁹,Lifke Valeria¹⁰,Corradini Veronika¹¹,Eichenlaub Udo¹⁰,Batrla Richard¹¹,Buck Katharina¹⁰,Zink Katharina¹⁰,Rabe Christina⁹,Blennow Kaj⁴⁵,Shaw Leslie M.¹², ,

Affiliation:

1. Clinical Memory Research UnitLund UniversityMalmöSweden

2. Memory ClinicSkåne University HospitalMalmöSweden

3. Institute for Neurodegenerative DisordersNew HavenCTUSA

4. Clinical Neurochemistry LaboratorySahlgrenska University HospitalMölndalSweden

5. Institute of Neuroscience and PhysiologyDepartment of Psychiatry and NeurochemistryThe Sahlgrenska Academy at University of GothenburgMölndalSweden

6. Department of Molecular NeuroscienceUCL Institute of NeurologyQueen SquareLondonUK

7. UK Dementia Research InstituteLondonUK

8. Center for Neurodegenerative Disease ResearchInstitute on Aging and Department of Pathology and Laboratory MedicinePhiladelphiaPAUSA

9. Former Employee of Roche Diagnostics GmbHPenzbergGermany

10. Roche Diagnostics GmbHPenzbergGermany

11. Roche Diagnostics InternationalRotkreuzSwitzerland

12. Department of Pathology and Laboratory MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPAUSA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.01.010

Reference46 articles.

1. Alzheimer's disease

2. Alzheimer's disease

3. American Academy of Neurology. AAN Guideline Summary for clinicians: detection diagnosis and management of dementia. 2004; July 2014. Available at:http://tools.aan.com/professionals/practice/pdfs/dementia_guideline.pdf. Accessed March 5 2018.

4. DSM-5 and Mental Disorders in Older Individuals

Cited by 453 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial;Neurology Clinical Practice;2024-04

2. Longitudinal trajectories of cognitive reserve in hypometabolic subtypes of Alzheimer's disease;Neurobiology of Aging;2024-03

3. Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection;Talanta;2024-02

4. Mapping the human brain proteome: opportunities, challenges and clinical potential;Expert Review of Proteomics;2024-02

5. CSF 14–3-3 zeta(ζ) isoform is associated with tau pathology and cognitive decline in Alzheimer's disease;Journal of the Neurological Sciences;2024-02